Dable Habib J
- SEC CIK
- 0001690773
No open-market purchases or sales filed in the past year.
Current role at each company
- PEPG PepGen Inc.Directoras of Jun 22, 2026
- RLAY Relay Therapeutics, Inc.Directoras of Jun 10, 2026
- DAWN Day One Biopharmaceuticals, Inc.Directoras of Apr 23, 2026
- TYRA Tyra Biosciences, Inc.Directoras of Apr 20, 2026
- SGP SpyGlass Pharma, Inc.Directoras of Feb 9, 2026
Show 4 more companies
- BPMC Blueprint Medicines CorpDirectoras of Jul 21, 2025
- JBIO Jade Biosciences, Inc.Directoras of Jun 7, 2024
- ALBO Albireo Pharma, Inc.Directoras of Mar 2, 2023
- XLRN Acceleron Pharma IncCEO and Presidentas of Nov 22, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dable Habib J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XLRN Acceleron Pharma Inc
CEO and President1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 (view filing) | Jul 1-2 | 1 day | Dable Habib JCEO and President | SSale | −100.0K | $126.83 | −$12.7M | −50.4%98.5K after | 8 lots |